SEOM clinical guideline on unknown primary cancer (2017)

Cancer of unknown primary site is a histologically confirmed cancer that manifests in advanced stage, with no identifiable primary site following standard diagnostic procedures. Patients are initially categorized based on the findings of the initial biopsy: adenocarcinoma, squamous-cell carcinoma, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Losa, F., Soler, G., Casado, A., Estival, A., Fernández, I., Giménez, S., Longo, F., Pazo-Cid, R., Salgado, J., Seguí, M. Á.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785607/
https://www.ncbi.nlm.nih.gov/pubmed/29230692
http://dx.doi.org/10.1007/s12094-017-1807-y
_version_ 1783295632285368320
author Losa, F.
Soler, G.
Casado, A.
Estival, A.
Fernández, I.
Giménez, S.
Longo, F.
Pazo-Cid, R.
Salgado, J.
Seguí, M. Á.
author_facet Losa, F.
Soler, G.
Casado, A.
Estival, A.
Fernández, I.
Giménez, S.
Longo, F.
Pazo-Cid, R.
Salgado, J.
Seguí, M. Á.
author_sort Losa, F.
collection PubMed
description Cancer of unknown primary site is a histologically confirmed cancer that manifests in advanced stage, with no identifiable primary site following standard diagnostic procedures. Patients are initially categorized based on the findings of the initial biopsy: adenocarcinoma, squamous-cell carcinoma, neuroendocrine carcinoma, and poorly differentiated carcinoma. Appropriate patient management requires understanding several clinical and pathological features that aid in identifying several subsets of patients with more responsive tumors.
format Online
Article
Text
id pubmed-5785607
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-57856072018-02-01 SEOM clinical guideline on unknown primary cancer (2017) Losa, F. Soler, G. Casado, A. Estival, A. Fernández, I. Giménez, S. Longo, F. Pazo-Cid, R. Salgado, J. Seguí, M. Á. Clin Transl Oncol Clinical Guides in Oncology Cancer of unknown primary site is a histologically confirmed cancer that manifests in advanced stage, with no identifiable primary site following standard diagnostic procedures. Patients are initially categorized based on the findings of the initial biopsy: adenocarcinoma, squamous-cell carcinoma, neuroendocrine carcinoma, and poorly differentiated carcinoma. Appropriate patient management requires understanding several clinical and pathological features that aid in identifying several subsets of patients with more responsive tumors. Springer International Publishing 2017-12-11 2018 /pmc/articles/PMC5785607/ /pubmed/29230692 http://dx.doi.org/10.1007/s12094-017-1807-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Clinical Guides in Oncology
Losa, F.
Soler, G.
Casado, A.
Estival, A.
Fernández, I.
Giménez, S.
Longo, F.
Pazo-Cid, R.
Salgado, J.
Seguí, M. Á.
SEOM clinical guideline on unknown primary cancer (2017)
title SEOM clinical guideline on unknown primary cancer (2017)
title_full SEOM clinical guideline on unknown primary cancer (2017)
title_fullStr SEOM clinical guideline on unknown primary cancer (2017)
title_full_unstemmed SEOM clinical guideline on unknown primary cancer (2017)
title_short SEOM clinical guideline on unknown primary cancer (2017)
title_sort seom clinical guideline on unknown primary cancer (2017)
topic Clinical Guides in Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785607/
https://www.ncbi.nlm.nih.gov/pubmed/29230692
http://dx.doi.org/10.1007/s12094-017-1807-y
work_keys_str_mv AT losaf seomclinicalguidelineonunknownprimarycancer2017
AT solerg seomclinicalguidelineonunknownprimarycancer2017
AT casadoa seomclinicalguidelineonunknownprimarycancer2017
AT estivala seomclinicalguidelineonunknownprimarycancer2017
AT fernandezi seomclinicalguidelineonunknownprimarycancer2017
AT gimenezs seomclinicalguidelineonunknownprimarycancer2017
AT longof seomclinicalguidelineonunknownprimarycancer2017
AT pazocidr seomclinicalguidelineonunknownprimarycancer2017
AT salgadoj seomclinicalguidelineonunknownprimarycancer2017
AT seguima seomclinicalguidelineonunknownprimarycancer2017

Ejemplares similares